Oral Vancomycin Effect in Primary Sclerosing Cholangitis

被引：0
|
作者：
Khan, Ruben [1 ]
Albugeaey, Mohammed [2 ]
Rangnekar, Amol S. [3 ]
机构：
[1] MedStar Georgetown Univ Hosp, Washington, DC USA
[2] MedStar Georgetown Univ Hosp, Dept Gastroenterol, Washington, DC USA
[3] MedStar Georgetown Univ Hosp, Dept Hepatol, Washington, DC USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2015年 / 110卷
关键词：
D O I：
10.14309/00000434-201510001-00911
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
911
引用
收藏
页码：S393 / S393
页数：1
相关论文
共 50 条
  • [1] ORAL VANCOMYCIN AS AN EFFECTIVE MONOTHERAPY FOR THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS
    Tsay, Cynthia
    Lemos, Leta
    Scudiere, Jennifer R.
    Cox, Kenneth
    Davies, Yinka
    GASTROENTEROLOGY, 2019, 156 (06) : S1325 - S1325
  • [2] Oral vancomycin in the treatment of primary sclerosing cholangitis-associated pouchitis
    Shen, Bo
    GASTROENTEROLOGY REPORT, 2021, 9 (03): : 274 - 275
  • [3] Risk of vancomycin-resistant enterococci in patients with primary sclerosing cholangitis treated with oral vancomycin
    Shah, A.
    Pakneshan, S.
    Macdonald, G. A.
    Martin, N.
    Callaghan, G.
    Burger, D.
    Tallis, C.
    Chao, C. Y.
    Morrison, M.
    Stuart, K. A.
    Holtmann, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 259 - 259
  • [4] Oral vancomycin: Treatment of primary sclerosing cholangitis in children with inflammatory bowel disease
    Cox, KL
    Cox, KM
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1998, 27 (05): : 580 - 583
  • [5] Oral Vancomycin Therapy in a Child with Primary Sclerosing Cholangitis and Severe Ulcerative Colitis
    Buness, Cynthia
    Lindor, Keith D.
    Miloh, Tamir
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2016, 19 (03) : 210 - +
  • [6] Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis
    Johnson, Kevin M.
    Fischer, Ryan T.
    Holtmann, Gerald J.
    Shah, Ayesha
    Alrabadi, Leina
    Lewindon, Peter
    HEPATOLOGY, 2021, 74 (03) : 1716 - 1717
  • [7] Oral vancomycin in a pediatric patient with primary sclerosing cholangitis and inflammatory bowel disease
    Martin, Cristo Yared Perez
    Alonso, Jose Ramon Alberto
    Chavez, Jenifer Gonzalez
    Ruiz, Maria Pilar Diaz
    Gonzalez, Marta Suarez
    Alonso, Javier Merino
    FARMACIA HOSPITALARIA, 2023, 47 (06) : T297 - T299
  • [8] The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis
    Halma, Jennifer Christine
    Cristoferi, Laura
    Carbone, Marco
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (10) : 2699 - 2700
  • [9] Effect of Vancomycin on Primary Sclerosing Cholangitis in Patients With Clostridioides difficile Infection
    Yadav, Devvrat
    Pardi, Darrell
    Khanna, Sahil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1393 - S1393
  • [10] Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis
    Deneau, Mark R.
    Mack, Cara
    Mogul, Douglas
    Perito, Emily R.
    Valentino, Pamela L.
    Amir, Achiya Z.
    DiGuglielmo, Matthew
    Draijer, Laura G.
    El-Matary, Wael
    Furuya, Katryn N.
    Gupta, Nitika
    Hochberg, Jessica T.
    Horslen, Simon
    Jensen, M. Kyle
    Jonas, Maureen M.
    Kerkar, Nanda
    Koot, Bart G. P.
    Laborda, Trevor J.
    Lee, Christine K.
    Loomes, Kathleen M.
    Martinez, Mercedes
    Miethke, Alexander
    Miloh, Tamir
    Mohammad, Saeed
    Ovchinsky, Nadia
    Rao, Girish
    Ricciuto, Amanda
    Sathya, Pushpa
    Schwarz, Kathleen B.
    Shah, Uzma
    Singh, Ruchi
    Vitola, Bernadette
    Zizzo, Andreanne
    Guthery, Stephen L.
    HEPATOLOGY, 2021, 73 (03) : 1061 - 1073
12345